Stock Track | Oscar Health Surges 5% Despite EPS Miss on Exceptional Revenue Growth

Stock Track

Nov 07, 2024

Shares of Oscar Health, Inc. (NYSE:OSCR) soared 5.27% in the last 24 hours, following the release of the company's third-quarter 2024 financial results. While Oscar Health reported a larger-than-expected loss per share, the company's strong revenue growth appears to have fueled investor enthusiasm.

Oscar Health's Q3 2024 revenue of $2.42 billion exceeded analyst estimates of $2.34 billion, representing a remarkable 68.30% increase compared to the same period last year. This exceptional revenue growth highlights the company's ability to expand its business and capture market share, despite operating in a highly competitive healthcare sector.

However, the company's earnings fell short of expectations, with a reported loss of $0.22 per share, missing the analyst consensus estimate of $0.19. While the earnings miss is a concern, investors seem to be focusing more on the company's top-line growth, which is a key driver of long-term profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1138089270"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1138089270\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1138089270?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-07 19:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138089270","market":"hk","top_or_hot":-1,"title":"Stock Track | Oscar Health Surges 5% Despite EPS Miss on Exceptional Revenue Growth","media":"Stock Track","content":"<p>Shares of Oscar Health, Inc. (NYSE:OSCR) soared 5.27% in the last 24 hours, following the release of the company's third-quarter 2024 financial results. While Oscar Health reported a larger-than-expected loss per share, the company's strong revenue growth appears to have fueled investor enthusiasm.</p>\n\n<p>Oscar Health's Q3 2024 revenue of $2.42 billion exceeded analyst estimates of $2.34 billion, representing a remarkable 68.30% increase compared to the same period last year. This exceptional revenue growth highlights the company's ability to expand its business and capture market share, despite operating in a highly competitive healthcare sector.</p>\n\n<p>However, the company's earnings fell short of expectations, with a reported loss of $0.22 per share, missing the analyst consensus estimate of $0.19. While the earnings miss is a concern, investors seem to be focusing more on the company's top-line growth, which is a key driver of long-term profitability.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oscar Health Surges 5% Despite EPS Miss on Exceptional Revenue Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oscar Health Surges 5% Despite EPS Miss on Exceptional Revenue Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-11-07 19:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Oscar Health, Inc. (NYSE:OSCR) soared 5.27% in the last 24 hours, following the release of the company's third-quarter 2024 financial results. While Oscar Health reported a larger-than-expected loss per share, the company's strong revenue growth appears to have fueled investor enthusiasm.</p>\n\n<p>Oscar Health's Q3 2024 revenue of $2.42 billion exceeded analyst estimates of $2.34 billion, representing a remarkable 68.30% increase compared to the same period last year. This exceptional revenue growth highlights the company's ability to expand its business and capture market share, despite operating in a highly competitive healthcare sector.</p>\n\n<p>However, the company's earnings fell short of expectations, with a reported loss of $0.22 per share, missing the analyst consensus estimate of $0.19. While the earnings miss is a concern, investors seem to be focusing more on the company's top-line growth, which is a key driver of long-term profitability.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1138089270","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138089270","pubTimestamp":1730977582,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Oscar Health, Inc.  soared 5.27% in the last 24 hours, following the release of the company's third-quarter 2024 financial results. While Oscar Health reported a larger-than-expected loss per share, the company's strong revenue growth appears to have fueled investor enthusiasm.Oscar Health's Q3 2024 revenue of $2.42 billion exceeded analyst estimates of $2.34 billion, representing a remarkable 68.30% increase compared to the same period last year. This exceptional revenue growth highli","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"尽管收入增长异常，每股收益未达预期，Oscar Health股价仍飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"Shares of Oscar Health, Inc. (NYSE:OSCR) soared 5.27% in the last 24 hours, following the release of the company's third-quarter 2024 financial results. While Oscar Health reported a larger-than-expected loss per share, the company's strong revenue growth appears to have fueled investor enthusiasm.\nOscar Health's Q3 2024 revenue of $2.42 billion exceeded analyst estimates of $2.34 billion, representing a remarkable 68.30% increase compared to the same period last year. This exceptional revenue growth highlights the company's ability to expand its business and capture market share, despite operating in a highly competitive healthcare sector.\nHowever, the company's earnings fell short of expectations, with a reported loss of $0.22 per share, missing the analyst consensus estimate of $0.19. While the earnings miss is a concern, investors seem to be focusing more on the company's top-line growth, which is a key driver of long-term profitability.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}